
|Videos|October 25, 2021
Dr. Campbell assesses adverse effects of finasteride in patients with alopecia and BPH
Author(s)Urology Times staff
“This study suggests that the treatment of a patient's underlying hypogonadism or sexual dysfunction may be protective in the use of finasteride for alopecia or BPH,” says Kevin J. Campbell, MD, MS.
Advertisement
In this video, Kevin J. Campbell, MD, MS, discusses the takeaways of the study, “Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence,” presented recently at the 2021 Sexual Medicine Society of North America Fall Scientific Meeting. Campbell is an assistant professor in the department of urology at the University of Florida, Gainesville.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












